Acıbadem Healthcare Group

The Acıbadem Healthcare Group is a Turkish healthcare institution, operating with 17.000 employees in 20 locations through a network of six general hospitals, medical centers, outpatient clinics, one ophthalmology center and laboratories.

Besides its partnership with Istanbul International Hospital and International Etiler Outpatient Clinic, Acıbadem expands outside of Istanbul with Izmir, Eskişehir and Bodrum hospitals and in Istanbul with Maslak and Beşiktaş (Fulya) hospitals. It was founded in 1992 by Mehmet Ali Aydınlar and Dr. Armağan Özel, who left the group in 2007. Aydınlar is still the CEO of the group. The largest shareholder of Acıbadem is IHH Healthcare.

Acıbadem offered its shares in a public offering in 2000 and put the funds received towards new investments to increase its capacity. Today, Acıbadem is the only healthcare institution whose shares are traded on the Borsa Istanbul (BIST).

Acıbadem Hospitals Group provides interpretation services in many languages. Interpreters offer assistance as needed including accompanying appointments and translating patient education materials. Interpretation services provided in the following languages:

Acıbadem maintains a communications network between the Hospital Information Communication System in which all the medical records of patients are stored in Acıbadem Hospitals. Within or between the hospitals, Acıbadem employs an advanced Visual Transfer System.

The Genetic Diagnosis Center offers genetic services.

Aiming to provide healthcare services according to the standards of the United States-oriented accreditation institution Joint Commission International, which supervises the quality of hospitals, Acıbadem has been accepted into the membership of the European Foundation for Quality Management (EFQM) and Kalder. ISO 9001 certificate is granted to the Acıbadem's Central Sterilization Units.

...
Wikipedia